Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02000141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study

Study acronym: ACER/AMN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: estimated 2000 to confirmed 1281v12
  2. Re-verified, no change to tracked fieldsv11
  3. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 2024 to Jan 2017
    • Study completion date: Jan 2034 to Jan 2027
    • Site details revised
    v10
  4. 6 versions Re-verified since Jan 13, 2015, no change to tracked fieldsv4-v9
  5. Lead sponsor: South West Sydney Local Health District to Professor Michael Bourkev3
  6. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: Jan 2034
    • Start date: Dec 2013 to Jan 2014
    • Site details revised
    • Study title shortened, about 6 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To enhance understanding of the risk factors for AMN, improve lesion assessment and prediction of submucosal invasive cancer, improve endoscopic resection efficacy, reduce complications of WF-EMR and improve the understanding of the progression of large lesions to cancer
Trial Details
NCT Number NCT02000141
Lead Sponsor Professor Michael Bourke
Conditions
(from sponsor)		 Colonic Polyps
Related terms Colonic Polyps
Enrollment 1,281 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov